Seegene Inc
Contact Us

Donation of COVID-19 testing reagents for 40,000 people to KAIST

Oct 28, 2021

Seegene and the Seegene Medical Foundation donate testing reagents and expenses for constant diagnosis of COVID-19 in kind to KAIST (Korea Advanced Institute of Science and Technology).


On October 28, a ceremony was held at KAIST's main campus in Daejeon for the donation of COVID-19 testing reagent in kind by the Seegene and Seegene Medical Foundation. The donation ceremony was held in the presence of about 10 people, including Seegene CEO Chun Jong-yoon, Seegene Medical Foundation Chairman Chun Jong-ki, KAIST President Lee Kwang-hyung, Provost and Executive Vice President Lee Seung-seop, and Vice President for Planning and Budget Kim Bo-won.


This donation was made based on the consensus between the two organizations to quickly prepare for the transition into new ‘Living with Covid-19’ policy, which will be implemented from the 1st of next month, and the business agreement signed in July. The purpose is to prevent the spread of COVID-19 at an early stage and support safe return to daily life by establishing a 'persistent diagnosis' system that allows easy testing and quick analysis of results inside the KAIST campus.


Seegene provides diagnostic reagents for 40,000 COVID-19 tests for the KAIST community. Seegene supports the conduct of COVID-19 testing and all necessary expenses for those wishing to be tested among school members by using the ‘Mobile Station,’ a mobile on-site testing laboratory installed inside the KAIST campus.


The ‘Mobile Station’ is a mobile laboratory developed by Seegene that can perform the entire process of diagnosing COVID-19, from sample collection to PCR test and the result analysis. KAIST members can check the results in about 3 hours after undergoing a simple COVID-19 test inside the school, and up to 7,500 people can be tested per day.


CEO Chun Jong-yoon said, "I am delighted to have a lasting relationship with KAIST through this donation following the agreement ceremony for joint research on molecular diagnosis, which we signed in July." He also said, "I hope this donation will help students return to their normal school life."